- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05880186
Influence of the Time of Day in the Effect of Caffeine on Maximal Fat Oxidation During Exercise in Women (CIRCAF_WOM)
Influence of the Time of Day in the Effect of Caffeine on Maximal Fat Oxidation During Exercise in Women. A Randomized, Crossover, Double-blind, and Placebo-controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Madrid
-
Pozuelo De Alarcón, Madrid, Spain, 28223
- Universidad Francisco de Vitoria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- To be non-smokers.
- To have low caffeine intake (i.e., < 50 mg of caffeine per day in the previous 2 months)
- To show no previous history of cardiopulmonary diseases or having suffered musculoskeletal injuries in the previous 6 months.
- To have a regular duration of their menstrual cycle for the previous 6 months.
- To confirm no existence of any type of menstrual disorders such as dysmenorrhea, amenorrhea, or strong symptoms associated with pre-menstrual syndrome.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Caffeine intake
Test in the morning A dose of 3 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test. Test in the evening A dose of 3 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test. |
To evaluate the influence of the time of the day (i.e., morning vs evening) on the effect of caffeine on maximal fat oxidation in women.
|
Placebo Comparator: Placebo intake
Test in the morning A dose of 3 mg/kg of placebo (Cellulose, Guinama, Valencia, Spain) was ingested before the beginning of each test. Test in the evening A dose of 3 mg/kg of placebo (Cellulose, Guinama, Valencia, Spain) was ingested before the beginning of each test |
To evaluate the influence of the time of the day (i.e., morning vs evening) on the effect of caffeine on maximal fat oxidation in women.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MFO
Time Frame: 2-months
|
Maximal fat oxidation during exercise
|
2-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FATmax
Time Frame: 2-months
|
The intensity of exercise that elicits MFO
|
2-months
|
RPE
Time Frame: 2-months
|
Rate of percevied exertion during exercise
|
2-months
|
FAT AND CHO oxidation
Time Frame: 2-months
|
Fat and carbohydrates oxidation
|
2-months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UFVitoria_2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dietary Supplement
-
University of British ColumbiaCompletedDietary Supplement: Ketone Supplement | Dietary Supplement: PlaceboCanada
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)CompletedHealthy | Dietary SupplementUnited States
-
Medical University of WarsawUnknown
-
Universidad Francisco de VitoriaCompletedPlacebo | Dietary SupplementSpain
-
Universidad de MurciaUniversidad Francisco de VitoriaCompleted
-
Universidad Francisco de VitoriaCompletedDietary Supplement | Sport PerformanceSpain
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; Beijing Shijitan Hospital, Capital Medical University and other collaboratorsRecruiting
-
NestléCompletedDietary SupplementUnited States, Singapore
-
NestléCompletedDietary SupplementUnited States
-
PharmanexClinical Research AustraliaRecruiting
Clinical Trials on Acute caffeine supplementation
-
Universidad de MurciaUniversidad Francisco de VitoriaCompleted
-
Universidad Francisco de VitoriaCompletedDietary Supplement | Sport PerformanceSpain
-
Loughborough UniversityActive, not recruitingLipid Metabolism Disorders | Appetitive Behavior | Glucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
Nathaniel JenkinsCompletedAcute Physiological Effects of Organic Guayusa ExtractUnited States
-
Universidad Francisco de VitoriaCompletedGenetic Predisposition | Caffeine | Fat BurnSpain
-
Western University, CanadaCompletedCaffeine Withdrawal | Acute Exercise | Memory DeficitsCanada
-
University of ConnecticutUnited States Department of DefenseRecruitingHeat Intolerance | Heat Stress | Fatigue; HeatUnited States
-
Poznan University of Physical EducationPoznan University of Life SciencesCompletedSupplementation | SportsPoland
-
The Jerzy Kukuczka Academy of Physical Education...Completed
-
Universidad de ZaragozaSuspendedFatigue | Injuries | Caffeine | Soccer | Females Xy | Biomechanical ParametersSpain